{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:56:58Z","timestamp":1788893818078,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bmcl.2018.04.055","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T12:00:06Z","timestamp":1524571206000},"page":"2055-2060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism"],"prefix":"10.1016","volume":"28","author":[{"given":"Hiroshi","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyunko","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihito","family":"Tsukumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikiya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kannami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Idei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sakairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Moritani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.04.055_b0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bmcl.2018.04.055_b0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bmcl.2018.04.055_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.bmcl.2018.04.055_b0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bmcl.2018.04.055_b0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.bmcl.2018.04.055_b0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1590\/S0004-27302006000400008","article-title":"The calcium-sensing receptor and related diseases","volume":"50","author":"D\u2019Souza-Li","year":"2006","journal-title":"Arq Bras Endocrinol Metab"},{"key":"10.1016\/j.bmcl.2018.04.055_b0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2018.04.055_b0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00774-006-0687-y","article-title":"Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels","volume":"24","author":"Kawata","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bmcl.2018.04.055_b0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2005.06.019","article-title":"Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism","volume":"109","author":"Nagano","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2018.04.055_b0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favourable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bmcl.2018.04.055_b0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2215\/CJN.07050714","article-title":"A randomized trial of cinacalcet versus vitamin D analogs as monotherapy in secondary hyperparathyroidism (PARADIGM)","volume":"10","author":"Wetmore","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bmcl.2018.04.055_b0060","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2215\/CJN.11501210","article-title":"Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns","volume":"6","author":"Akizawa","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bmcl.2018.04.055_b0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2215\/CJN.13081211","article-title":"Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study","volume":"7","author":"Fukagawa","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bmcl.2018.04.055_b0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/kisup.2013.91","article-title":"Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan","volume":"3","author":"Fukuma","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.bmcl.2018.04.055_b0075","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.bmcl.2018.04.055_b0080","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bmcl.2018.04.055_b0085","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2018.04.055_b0090","doi-asserted-by":"crossref","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials","volume":"10","author":"Palmer","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.bmcl.2018.04.055_b0095","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/0091270007304103","article-title":"Effect of cinacalcet hydrochloride, a new calcimimetic agent, on the pharmacokinetics of dextromethorphan: in vitro and clinical studies","volume":"47","author":"Nakashima","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2018.04.055_b0100","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2018.04.055_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1542-4758.2009.00397.x","article-title":"Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients","volume":"14","author":"Gincherman","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.bmcl.2018.04.055_b0110","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1124\/dmd.108.022376","article-title":"The molecular basis of CYP2D6-mediated N-dealkylation: balance between metabolic clearance routes and enzyme inhibition","volume":"36","author":"Bonn","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmcl.2018.04.055_b0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/cr.2016.36","article-title":"Towards a structural understanding of allosteric drugs at the human calcium-sensing receptor","volume":"26","author":"Leach","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.bmcl.2018.04.055_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10822-008-9242-3","article-title":"Structural pairwise comparisons of HLM stability of phenyl derivatives: Introduction of the Pfizer metabolism index (PMI) and metabolism-lipophilicity efficiency (MLE)","volume":"23","author":"Lewis","year":"2009","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmcl.2018.04.055_b0125","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1074\/jbc.M202113200","article-title":"Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor","volume":"277","author":"Ray","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.04.055_b0130","doi-asserted-by":"crossref","unstructured":"With reference to our patent of this (S)-pyrrolidines (Miyazaki H, et al. WO2005115975A1), different physicochemical property adjustments also have recently been carried out. Sparks SM, Spearing PK, Diaz CJ, et al. Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration. Bioorg Med Chem Lett 2017; 27: 4673\u20134677.","DOI":"10.1016\/j.bmcl.2017.09.008"},{"key":"10.1016\/j.bmcl.2018.04.055_b0135","doi-asserted-by":"crossref","unstructured":"Evocalcet (16) was synthesized by Crabtree\u2019s catalyst under an atmosphere tritium gas in DMF at room temperature. The positions of the labels were not specified. Yu RM, Hesk D, Rivera N, et al. Iron-catalysed tritiation of pharmaceuticals. Nature 2016; 529: 195\u2013199.","DOI":"10.1038\/nature16464"},{"key":"10.1016\/j.bmcl.2018.04.055_b0140","doi-asserted-by":"crossref","first-page":"e0195316","DOI":"10.1371\/journal.pone.0195316","article-title":"A novel calcimimetic agent, evocalcet (MT-4580\/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and vitro","volume":"13","author":"Kawata","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2018.04.055_b0145","first-page":"B7","article-title":"Head-to-head efficacy and safety comparisons of a novel calcimimetic agent (evocalcet) with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism: a randomized clinical trial [Abstract]","volume":"28","author":"Fukagawa","year":"2017","journal-title":"J Am Soc Nephrol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18303676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18303676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:23:08Z","timestamp":1760772188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18303676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0960894X18303676"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.04.055","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}